ACE and COVID-19: Indeed, several recent studies hypothesized that COVID-19 patients receiving ACE-inhibitors may be subject to poorer outcomes [68, 69], whereas other investigators argued that the usage of ACE-inhibitors could be beneficial in COVID-19 infection [70].